---

Alex Kain

---

Alex joined Talisman in 2024.  Alex previously served on the senior leadership team of Specialty Networks, a healthcare technology-enabled group purchasing, data & analytics, and physician practice enhancement organization, where he led strategy, development, and growth through the company’s $1.2B sale.  Prior to Specialty Networks, Alex held various operating and investing roles, including with Pharmacy Specialty Group, Sheridan Capital Partners, and Cressey & Company.  Alex began his career in mergers and acquisitions with Lazard in New York City.
 
Alex graduated with an MBA from The Wharton School of the University of Pennsylvania and a BS in Finance from Indiana University’s Kelley School of Business.